Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efficient group sequential designs when there are several effect sizes under consideration.

Christopher Jennison1, Bruce W Turnbull

  • 1Department of Mathematical Sciences, University of Bath, Bath, BA2 7AY, U.K.

Statistics in Medicine
|October 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonists.

Genome medicine·2026
Same author

Clinical trials with interim analyses: standardizing terminology to increase clarity.

Trials·2025
Same author

Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A Tutorial.

Statistics in medicine·2025
Same author

Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists.

medRxiv : the preprint server for health sciences·2023
Same author

Discussion on "Adaptive enrichment designs with a continuous biomarker" by N. Stallard.

Biometrics·2022
Same author

Robust group sequential designs for trials with survival endpoints and delayed response.

Biometrical journal. Biometrische Zeitschrift·2021

This study introduces efficient group sequential designs for clinical trials, focusing on minimizing sample size across various anticipated effect sizes. Class B designs offer a practical balance of simplicity and efficiency, closely matching complex adaptive methods.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Methods

Background:

  • Group sequential designs are crucial for efficient clinical trials, balancing statistical rigor with resource optimization.
  • Standard and adaptive designs aim to maintain Type I error and power while controlling sample size.
  • Optimizing expected sample size across a range of effect sizes is a key challenge in trial design.

Purpose of the Study:

  • To construct efficient group sequential designs with low expected sample size at the null, alternative, and optimistic effect sizes.
  • To compare the performance of four nested classes of group sequential and adaptive designs.
  • To identify simple yet efficient designs suitable for practical application in clinical research.

Main Methods:

  • Investigated four nested classes of designs: rho-family group sequential (A), unequal initial group size (B), fixed arbitrary boundaries (C), and adaptive designs (D).

Related Experiment Videos

  • Evaluated optimal procedures within each class based on expected sample size, Type I error rate, and power.
  • Utilized tables and figures to illustrate design performance and define optimal procedures.

    • Main Results:

    • Class B designs, featuring unequal initial group sizes, demonstrated high efficiency.
    • The performance of Class B designs closely approached that of more complex Class C and D designs.
    • Optimal procedures within Class A and B were identified and illustrated.

    Conclusions:

    • Class B group sequential designs offer a compelling combination of simplicity and efficiency.
    • These designs provide a practical alternative to more complex adaptive procedures without significant loss in efficiency.
    • The findings support the use of Class B designs for constructing efficient clinical trials across various anticipated effect sizes.